Press release
Leader in pain therapeutics chooses PAS-X PROCESS DEVELOPMENT
Grünenthal bundles all research and development activities at its campus in Aachen, Germany. Source: Grünenthal
Werum's software product ensures transparent management of starting materials in pharmaceuticals development at Grünenthal, Germany
Lueneburg, Germany, 29 May 2013 – The research-based international pharmaceutical company Grünenthal will deploy the PAS-X PROCESS DEVELOPMENT package. The group is leading in the field of pain therapies and invests more than a quarter of its revenues in research and development. Operating Werum's PAS-X PROCESS DEVELOPMENT, pharmaceutical and biotech companies can simplify and accelerate the modeling of manufacturing processes for pre-clinical and clinical studies. Grünenthal will initially install the package for substance tracking of clinical batches at its plant in Aachen, Germany.
“With PAS-X PROCESS DEVELOPMENT we are capable of tracking the use and consumption of all raw materials in pharmaceutical development,” says Dr. Martin Lueck, Vice President Head of Pharmaceutical Development & Drug Delivery at Grünenthal. “This enables us to further increase the efficiency of our development activities.”
In addition to PAS-X PROCESS DEVELOPMENT, Grünenthal will also deploy the PAS-X business functions MASTER BATCH RECORDS, WAREHOUSE MANAGEMENT and WEIGHING & DISPENSING.
About Grünenthal
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. These investments amounted to about 26 percent of revenues in 2012. Grünenthal’s research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. The pharmaceutical group is intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies. Altogether, the Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal products are sold in more than 155 countries. Today, approx. 4,400 employees are working for the Grünenthal Group worldwide. In 2012, Grünenthal achieved revenues of € 973 mn. Additional information is available at www.grunenthal.com.
About Werum Software & Systems AG
With over 40 years of software development experience, Werum Software & Systems AG is known worldwide for partnering with its global customers to create state-of-the-art software products and solutions. Werum is the internationally leading supplier of Manufacturing IT / Manufacturing Execution Systems (MES) for the pharmaceutical and biopharmaceutical industries. Its PAS-X Manufacturing IT Business Platform is used by 16 of the world’s top 30 pharmaceutical and biotech companies in more than 600 installations. Founded in 1969, the IT company employs about 470 people at its headquarters in Lueneburg, Germany, and at nine other locations in Germany, France, Switzerland, the United States, Japan, and Singapore. For more information take a look at our websites at www.werum.com and www.pas-x.com.
Dirk Ebbecke
Director Corporate Communications
Werum Software & Systems AG
Wulf-Werum-Strasse 3
21337 Lueneburg, Germany
Tel. +49 4131 8900-689
Fax +49 4131 8900-20
dirk.ebbecke@werum.com
For further information, visit Werum’s press center at www.press.werum.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leader in pain therapeutics chooses PAS-X PROCESS DEVELOPMENT here
News-ID: 261913 • Views: …
More Releases from Werum Software & Systems AG
Research Made Easy
With their web-based data management system DSHIP the German-based company Werum Software & Systems supports maritime research on board of research vessels all over the world.
The Instagram profile of the current climate research expedition MOSAiC in the North Polar Sea shows straightaway: research work on the high seas may be really fascinating, but it also is extremely laborious, fragmented and highly complex. As they depend on the various environmental conditions…
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES imp …
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES implementation times
Best practice consulting services and “Out of the Box”-templates for GMP-compliant reports and labels
Lueneburg, Germany, 29 January 2014 – By providing "PAS-X Reports & Labels" Content Packages, Werum Software & Systems now offers an even broader range of pre-configured reports and labels along with the associated comprehensive consulting services to its customers.
These packages are based on best practices…
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content …
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content Packages
New "PAS-X MBR Design Elements" Content Packages based on industry best practice / process-specific and fast MBR creation for pharmaceutical production
Lueneburg, Germany, 28 November 2013 – In order for pharma and biotech customers to implement PAS-X MES projects even faster and more easily, Werum Software & Systems expands its PAS-X Content Packages offering further: New on the market are…
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP softw …
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP software
AWI puts new RV Mya II into service / Werum's data management system DSHIP ensures acquisition, archiving and evaluation of measurement data
Lueneburg, Germany, 23 October 2013 – The new RV Mya II, which has only recently been delivered to the German Alfred Wegener Institute, Helmholtz Center for Polar and Marine Research (AWI), has been equipped by Werum Software…
More Releases for Grünenthal
Middle East Tapentadol Market is Thriving Worldwide | Top Players : Depomed, Jan …
New Study Reports ” Middle East Tapentadol Market 2021, Global Key Players Analysis, Share, Trends, Business Updates, Future Opportunities Forecasts to 2028″ has been Added. In terms of revenue, the global Middle East Tapentadol market was valued at US$ 0.82 Mn in 2020 and is expected to reach US$ 1.46 Mn by 2028 growing at a CAGR of 6.1% over the forecast period. At present, the market is…
Global Furazolidone market: Top Investment Pockets in the Market|Daiichi Sankyo, …
Los Angeles, United State: The report is a compilation of comprehensive research studies on various aspects of the global Furazolidone Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real, transparent picture of current and future situations of the global Furazolidone market. Market participants can use this powerful tool when creating effective business plans or making important changes to their strategies. The report…
Neuropathic Pain Management Market Exclusive insight on Transformation 2029 | Gr …
Global Neuropathic Pain Management Market: Overview
Neuropathic pain is defined as pain that occurs due to damage to nerve endings, usually on the surface of the body. The pain feels like a needle stab or an electric shock. Other common qualities associated with this pain include a burning or cold sensation, a “pins and needles” sensations, numbness and itching. A number of chronic diseases lead to the occurrence of neuropathic pain,…
Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | A …
Complex regional pain syndrome (CRPS) is a type of chronic pain that affects one limb of the body (hand, leg, arm, or foot). The condition generally arises due to severe injuries or malfunctioning of central and peripheral nervous systems.
Download the sample report @ https://www.pharmaproff.com/request-sample/1096
CRPS is categorized into two main types: CRPS-I and CRPS-II. CRPS-I is associated with unconfirmed nerve injury; whereas, CRPS-II is associated with confirmed nerve injury. CRPS…
Middle East Tapentadol Market Key Developments, Footprint with Major Key Players …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
Middle East Tapentadol Market Top Players, Industry Size Depomed,Janssen Pharmac …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
